← All trials
NCT03077048
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 30, 2017
- Primary completion
- Apr 27, 2018
- Completion date
- May 2, 2018
- First posted
- Mar 10, 2017
- Last posted
- May 14, 2018
- Enrollment
- 23
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- FreseniusLead sponsor
- EastHORN Clinical ServicesCollaborator
- FreseniusStudy chair
- MLM Medical Labs GmbHCollaborator
- ALS Czech Republic, s.r.o.Collaborator
- FreseniusOfficial
- PCG Clinical Services ABCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.